| |
| |
|
| Insider
Information: |
Duliege Anne-Marie |
| Relationship: |
EVP & Chief Medical Of... |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
28,125 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
28,125 |
|
|
| Total
Value |
$20 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Affymax Inc |
AFFY |
Chief Medical Officer |
2013-01-30 |
28,125 |
2008-05-15 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
EVP, Chief of Strategi... |
2014-11-18 |
0 |
2014-11-18 |
0 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
EVP & Chief Medical Of... |
2018-09-17 |
0 |
2017-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2018-09-17 |
4 |
AS |
$3.50 |
$535,500 |
D/D |
(153,000) |
0 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2018-09-17 |
4 |
OE |
$2.11 |
$372,495 |
D/D |
153,000 |
37,500 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2018-09-04 |
4 |
AS |
$3.51 |
$57,861 |
D/D |
(16,500) |
0 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2018-09-04 |
4 |
OE |
$2.54 |
$41,910 |
D/D |
16,500 |
16,500 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2018-07-02 |
4 |
AS |
$2.79 |
$13,932 |
D/D |
(5,000) |
0 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2018-04-20 |
4 |
AS |
$4.11 |
$20,550 |
D/D |
(5,000) |
0 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2017-07-05 |
4 |
AS |
$2.69 |
$13,427 |
D/D |
(5,000) |
0 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2017-01-03 |
4 |
AS |
$2.41 |
$12,028 |
D/D |
(5,000) |
0 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
EVP, Chief of Strategic Dev. |
• – – |
2014-11-18 |
4 |
AS |
$4.71 |
$23,432 |
D/D |
(4,970) |
0 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2013-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
28,125 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2012-11-01 |
4 |
AS |
$22.90 |
$24,182 |
D/D |
(1,056) |
23,125 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2012-10-10 |
4 |
AS |
$24.00 |
$232,896 |
D/D |
(9,704) |
23,125 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2012-09-13 |
4 |
AS |
$20.00 |
$464,540 |
D/D |
(23,227) |
32,829 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2012-09-13 |
4 |
OE |
$4.36 |
$140,510 |
D/D |
23,227 |
56,056 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2012-05-25 |
4 |
AS |
$14.11 |
$52,052 |
D/D |
(3,689) |
32,829 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2011-08-17 |
4 |
S |
$4.73 |
$25,050 |
D/D |
(5,296) |
24,704 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2011-06-23 |
4 |
S |
$6.47 |
$26,029 |
D/D |
(4,023) |
30,000 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2010-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2010-03-16 |
4 |
AS |
$20.96 |
$52,400 |
D/D |
(2,500) |
0 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2010-03-16 |
4 |
OE |
$0.80 |
$2,000 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2010-03-15 |
4 |
AS |
$20.88 |
$450,610 |
D/D |
(21,583) |
0 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2010-03-15 |
4 |
OE |
$0.80 |
$148,002 |
D/D |
21,583 |
21,583 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2009-11-10 |
4 |
OE |
$0.80 |
$2,400 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2009-11-10 |
4 |
AS |
$20.27 |
$60,810 |
D/D |
(3,000) |
0 |
0 |
- |
|
| AFFY |
Affymax Inc |
Chief Medical Officer |
• – – |
2009-09-03 |
4 |
AS |
$22.00 |
$71,500 |
D/D |
(3,250) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
